Eyecelerator 2020
Virtual Conference | Friday, Nov. 6
8 a.m. - 4:30 p.m. PT
Attend the only innovation meeting that matters — now 100% online
CONFERENCE PROGRAM
Eyecelerator Overview
9:00 – 9:05 a.m. a.m.
David W. Parke II, MD, Steve Speares, Gil Kliman, MD, Vance Thompson, MD, Mark S. Blumenkranz MD
The 3C's: Impact of COVID, Capital Markets and Consolidation
8:05 – 9:05 a.m.
Top executive leads a sequence of multidisciplinary panel discussions that examine the key forces reshaping ophthalmic innovation.
​
Moderator: Jim Mazzo
​
Panel 1:
Eric D. Donnenfeld, MD; Mark S. Humayun, MD, PhD; Jeffrey J. Kimbell, (Jeffrey J. Kimbell & Associates, Inc.); Jim Momtazee (Patient Square Capital)
Panel 2:
Larry Biegelsen (Wells Fargo); Mike Giaquinto (SVBLeerink); Gil Kliman, MD, (InterWest Partners); Elizabeth Yeu, MD
​
Innovations for Practice Recovery and Growth
9:05 – 10:05 a.m.
Rapidly accelerating advances in diagnostics, therapeutics, tele-health, patient flow.
​
Vance Thompson, MD; Ranya Habash, MD; Eduardo C. Alfonso, MD
​
Mad Eye Money
10:05 – 10:28 a.m.
Strap in for a lightning round of market analysis and ideas for financing innovation.
​
Moderator: Gil Kliman, MD
Panelists: Jon Norris (Silicon Valley Bank); Brian Scullion (William Blair); Michael Lachman (EyeQ Research)
​
Inside the Global Game, Pt. I
10:28 – 10:43 a.m.
The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships.
​
Moderator: David W. Parke II, MD
Strategic discussion with Johnson & Johnson Vision
-
Warren Foust, Worldwide President, Surgical Vision
-
Raj Rajpal, MD, CMO, Global Head of Clinical and Medical Affairs
-
Xiao-YuSong, MD, PhD, Global Head of Research & Development
​
Company Showcase I: Anterior Segment/Glaucoma
10:43 a.m.– 12:17 p.m.
Moderators: Lama A. Al Aswad, MD and Ranya Habash, MD
​
➢ Presbyopia/Myopia
1. LensGen
2. Visus Therapeutics
3. Yolia Health
4. SightGlass Vision, Inc.
➢ Cornea/Dry Eye
1. Aperta Biosciences
2. TearClear
3. SilkTech Biopharmaceuticals
4. Trefoil Therapeutics
5. EyeYon Medical
➢ Drug Delivery
1. Emmecell
2. AnkyrBio, LLC
3. Kedalion Therapeutics
➢ Devices and Sensors
1. Centricity Vision, Inc.
2. PreVista
3. Infinite Medical Ventures
4. Implandata Ophthalmic Products GmbH
5. Injectsense, Inc.
​
Inside the Global Game, Pt. II
12:17 – 12:32 p.m.
The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships.
​
Moderator: David W. Parke II, MD
Strategic discussion with Alcon
-
Alan Landers, OD, MS, Head, Search & Evaluation BD&L Vision Care
-
Shannon Spock, Surgical Search and Evaluation Head, Business Development and Licensing
-
Costin Curatu, Head, Search and Evaluation, Surgical BD&L
​
Company Showcase II: Retina Secreted Factors, Genes, Devices
12:32 – 12:59 p.m.
Uncover key insights for advancing partnerships with industry giants.
​
Moderators: Mark Blumenkranz, MD and Allen Ho, MD
​
1. Neurotech Pharmaceuticals, Inc.
2. Aviceda Ophthalmics
3. Gensight Biologics
4. Notal Vision,Inc.
5. Pixium Vision
​
Opportunities & Challenges for Medium-Sized Companies
12:59 – 1:19 p.m.
Uncover key insights for advancing partnerships with industry giants.
​
Moderators: Allen Ho, MD and Sean Ianchulev, MD
​
Panelists:
-
Wiley Chambers, MD (FDA)
-
Pravin Dugel, MD (Iveric Bio)
-
Rick Eiswirth (Alimera Sciences)
-
Cedric Francois, MD, PhD (Apellis)
-
Hylton Kalvaria (Verana Health)
-
Aaron Osborne (Adverum Biotech)
-
Ram Palanki (RegenxBio)
​
Company Showcase III: Advancing Trials in the Public Eye
1:19 – 1:46 p.m.
Moderators: Mark Blumenkranz, MD and Allen Ho, MD
​
1. AldeyraTherapeutics, Inc.
2. Kubota Vision
3. Ocular Therapeutix
4. Lineage Cell Therapeutics, Inc.
5. Verana Health
Inside the Global Game, Pt. III
1:46 – 2:01 p.m.
The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships.
​
Strategic discussion with Allergan, an AbbVie company
-
Jag Dosanjh, Senior Vice President, Medical Therapeutics
-
Michael R. Robinson, MD, Vice President, Global Therapeutic Area Head Ophthalmology
-
Doug Faunce, PhD, Executive Director, Search and Evaluation-Eyecare Abbvie Corporate Strategy
​
Opportunities and Challenges for Large Companies
2:01 – 2:21 p.m.
Uncover key insights for advancing partnerships with industry giants.
​
Moderator: Mark Blumenkranz, MD
​
Panelists:
-
Abu Abraham, MD (Santen)
-
Anthony Adamis, MD (Genentech)
-
Eddy Anglade, MD (Johnson & Johnson Vision/Janssen)
-
Laurent Attias (Alcon)
-
Andrew Gitkin (Raymond James)
-
Chuck Hess (Bausch + Lomb)
-
Angelo Rago (Zeiss)
-
Dirk Sauer, PhD (Novartis)
-
Jonathan Weyne, MD (Regeneron)
​
Inside the Global Game, Pt. IV
2:21 – 2:36 p.m.
The Academy's CEO sits down with executives from global health care giants to uncover key insights for advancing innovation partnerships.
​
Moderator: David W. Parke II, MD
Strategic discussion with Zeiss
-
Euan S. Thomson, PhD, President
-
Steve Schallhorn, MD, Chief Medical Officer
-
Andy Chang, Head of Global Sales
​
Rise of The Machines
2:36 – 3:36 p.m.
Robotics and brain-machine interfaces are still in their infancy but they have the potential to improve outcomes for ophthalmic patients by enabling digitally-driven therapies. Take a peek over the horizon at the emerging fields of robotics and brain machine interfaces with "the father of robotic surgery."
​
Moderators: Ranya Habash, MD (BMI) and Gil Kliman, MD (Robotics)
Keynote – Fred Moll, MD
Chief Development Officer, Johnson & Johnson Medical Devices
Founder, Intuitive Surgical and Auris Health
Panelists: Dimitri Azar, MD, (Verily Life Sciences); Linda Lam MD, Associate Professor of Ophthalmology (USC Keck School of Medicine); Reza Zadno, CEO (Procept Biorobotics); Marc de Smet, MD, CMO (Preceyes); Doug Kelly, MD (FDA)
​
Cultivating Diversity in Innovation
3:36 – 4:21 p.m.
First-of-its-kind session explores the importance and measurable value of building a diverse community to advance new technology and treatments.
​
Moderators: Lama A. Al-Aswad, MD, MPH and Deepinder K. Dhaliwal, MD, L.Ac
Keynote – The Mix That Matters: Innovation Through Diversity
Karin Schetelig, Principal, The Boston Consulting Group
Panelists: Caren Mason (STAAR Surgical); Jag Dosanjh (Allergan, an AbbVie company); Ramgopal Rao (LensGen, Inc.); Todd Pinkney (Centricity Vision)
​
Best of Show and Closing Remarks
4:21 – 4:30 p.m.
Eyecelerator Company Pick and and People's Choice Company Pick
​
Presented by Co-chairs Gil Kliman, MD, Mark Blumenkranz, MD, Vance Thompson, MD
​
12:17 – 12:32 p.m.
Inside the Global Game, Pt. II
Uncover key insights for advancing partnerships with industry giants.
Moderator: David W. Parke II, MD
Strategic discussion with Alcon
-
Alan Landers, OD, MS, Head, Search & Evaluation BD&L Vision Care
-
Shannon Spock, Surgical Search and Evaluation Head, Business Development and Licensing
-
Costin Curatu, Head, Search and Evaluation, Surgical BD&L
​
12:32 – 12:59 p.m.
Company Showcase II: Retina Secreted Factors, Genes, Devices
Moderators: Mark Blumenkranz, MD and Allen Ho, MD
​
1. Neurotech Pharmaceuticals, Inc.
2. Aviceda Ophthalmics
3. Gensight Biologics
4. Notal Vision,Inc.
5. Pixium Vision
​